tiprankstipranks

James H. Cavanaugh Insider Profile

4 Followers
James H. Cavanaugh, Director, Ten Percent Owner at Altimmune, holds 3.30M shares in Altimmune (Ticker: ALT), holds 262.05K shares in Leap Therapeutics (Ticker: LPTX). Most recently, James H. Cavanaugh ― shares of Altimmune on ― for an estimated value of ―.
tipranks
James H. Cavanaugh

James H. Cavanaugh
Altimmune (ALT)
Director, Ten Percent Owner

Not Ranked
James H. Cavanaugh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$29M
97.72%
2.28%
A breakdown of James H. Cavanaugh's holdings

Insider Roles

Altimmune
(ALT)
Director, Ten Percent Owner
Leap Therapeutics
(LPTX)
Director
Roles that James H. Cavanaugh holds in companies

Most Profitable Insider Trade

Stock:
Leap Therapeutics
(LPTX)
Rating:Informative Buy
Date:Nov 15, 2024 - Today
Return:-6.90%
The most profitable trade made by James H. Cavanaugh

James H. Cavanaugh's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Altimmune
Director, Ten Percent Owner
$28.26M
Leap Therapeutics
Nov 15, 2024
Director
Informative Buy
600.66
$660.37K
List of latest transactions for each holding click on a transaction to see James H. Cavanaugh's performance on stock

James H. Cavanaugh insider profile FAQ

What is the percentage of profitable transactions made by James H. Cavanaugh?
The percentage of profitable transactions made by James H. Cavanaugh is ―.
    What is the average return per transaction made by James H. Cavanaugh?
    The average return per transaction made by James H. Cavanaugh is ―.
      What stocks does James H. Cavanaugh hold?
      James H. Cavanaugh holds: ALT, LPTX stocks.
        What was James H. Cavanaugh’s latest transaction?
        James H. Cavanaugh latest transaction was an Uninformative Buy of ―.
          What was James H. Cavanaugh's most profitable transaction?
          James H. Cavanaugh’s most profitable transaction was an Informative Buy of LPTX stock on November 15, 2024. The return on the trade was -6.90%.
            What is James H. Cavanaugh's role in Altimmune?
            James H. Cavanaugh's role in Altimmune is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.